Table 1.

Comparison of SCD patients and controls

SCD subjects (n = 44)Controls (n = 33)P
BMI, kg/m2    
 Median (IQR) 18.1 (16.77-20.40) 21.6 (19.91-25.71) <.001 
O2saturation, %    
 Median (IQR) 95.0 (92-98) 98.0 (96-99) <.001 
sP-selectin, ng/mL    
 Median (IQR) 78.70 (29.40-93.10) 72.7 (14.10-89.50) <.001 
HbF, ng/mL    
 Median (IQR) 373.30 (316.80-448.28) 273.90 (212.23-332.23) <.001 
HCY, μmol/L    
 Median (IQR) 16.4 (10.18-28.83) 8.3 (5.00-18.65) <.001 
KIM1, ng/mL    
 Median (IQR) 0.45 (0.32-0.62) 0.13 (0.12-0.18) <.001 
CysC, mg/L    
 Median (IQR) 4.8 (1.6-7.9) 1.1 (0.5-1.6) <.001 
CFA IMT, mm    
 Median (IQR) 0.8 (0.63-1.0) 0.6 (0.60-0.70) <.001 
SCD subjects (n = 44)Controls (n = 33)P
BMI, kg/m2    
 Median (IQR) 18.1 (16.77-20.40) 21.6 (19.91-25.71) <.001 
O2saturation, %    
 Median (IQR) 95.0 (92-98) 98.0 (96-99) <.001 
sP-selectin, ng/mL    
 Median (IQR) 78.70 (29.40-93.10) 72.7 (14.10-89.50) <.001 
HbF, ng/mL    
 Median (IQR) 373.30 (316.80-448.28) 273.90 (212.23-332.23) <.001 
HCY, μmol/L    
 Median (IQR) 16.4 (10.18-28.83) 8.3 (5.00-18.65) <.001 
KIM1, ng/mL    
 Median (IQR) 0.45 (0.32-0.62) 0.13 (0.12-0.18) <.001 
CysC, mg/L    
 Median (IQR) 4.8 (1.6-7.9) 1.1 (0.5-1.6) <.001 
CFA IMT, mm    
 Median (IQR) 0.8 (0.63-1.0) 0.6 (0.60-0.70) <.001 

or Create an Account

Close Modal
Close Modal